Review: Adjuvant recombinant subunit vaccine prevents herpes zoster more than live attenuated vaccine in adults ≥ 50 years

被引：0
|
作者：
Sacks, Henry S. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2019年 / 170卷 / 04期
关键词：
D O I：
10.7326/ACPJ201902190-014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：JC14 / JC14
页数：1
相关论文
共 50 条
  • [41] Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older
    Ackerson, Bradley
    Qian, Lei
    Sy, Lina S.
    Bruxvoort, Katia
    Wu, Jun
    Luo, Yi
    Diaz-Decaro, John
    Talarico, Carla
    Tseng, Hung Fu
    VACCINE, 2021, 39 (06) : 926 - 932
  • [42] Safety of live attenuated herpes zoster vaccine in Australian adults 70-79 years of age: an observational study using active surveillance
    Phillips, Anastasia
    Glover, Catherine
    Leeb, Alan
    Cashman, Patrick
    Fathima, Parveen
    Crawford, Nigel
    Snelling, Thomas L.
    Durrheim, David
    Macartney, Kristine
    BMJ OPEN, 2021, 11 (03):
  • [43] Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
    Le, Phuc
    Rothberg, Michael B.
    JAMA INTERNAL MEDICINE, 2018, 178 (02) : 248 - 258
  • [44] Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years
    Tseng, Hung Fu
    Harpaz, Rafael
    Luo, Yi
    Hales, Craig M.
    Sy, Lina S.
    Tartof, Sara Y.
    Bialek, Stephanie
    Hechter, Rulin C.
    Jacobsen, Steven J.
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (12): : 1872 - 1875
  • [45] Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older
    Shiragami, Makoto
    Mizukami, Akiko
    Kaise, Toshihiko
    Curran, Desmond
    Van Oorschot, Desiree
    Bracke, Benjamin
    Watanabe, Daisuke
    DERMATOLOGY AND THERAPY, 2019, 9 (02) : 281 - 297
  • [46] Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older
    Makoto Shiragami
    Akiko Mizukami
    Toshihiko Kaise
    Desmond Curran
    Desiree Van Oorschot
    Benjamin Bracke
    Daisuke Watanabe
    Dermatology and Therapy, 2019, 9 : 281 - 297
  • [47] Effectiveness of Recombinant Herpes Zoster Vaccine by Immune Status and Prior Receipt of Live Zoster Vaccine in Medicare Enrollees, 2018-2019
    Fix, Jonathan
    Vielot, Nadja A.
    Funk, Michele Jonsson
    Sturmer, Til
    Weber, David
    Becker-Dreps, Sylvia
    Lund, Jennifer L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 90 - 90
  • [48] Prevention of herpes zoster infection with a recombinant zoster vaccine to support healthy ageing in older adults
    Ankobia, A.
    Curran, D.
    Doherty, T. M.
    Lecrenier, N.
    Breuer, T.
    AGE AND AGEING, 2024, 53
  • [49] Exacerbation of Herpes Zoster Ophthalmicus (HZO) Following Zoster Vaccine, Live, Attenuated [Oka/Merck]: A Case Series
    Taylor, Elaine
    Legare, C.
    Duc Vu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 441 - 441
  • [50] Safety and immunogenicity of adjuvanted recombinant subunit herpes zoster vaccine in lung transplant recipients
    Hirzel, Cedric
    L'Huillier, Arnaud G.
    Ferreira, Victor H.
    Marinelli, Tina
    Ku, Terrance
    Ierullo, Matthew
    Miao, Congrong
    Schmid, D. Scott
    Juvet, Stephen
    Humar, Atul
    Kumar, Deepali
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (06) : 2246 - 2253
12345